Cyxone AB Logo

Cyxone AB

A clinical-stage biotech developing therapies for autoimmune and autoinflammatory diseases.

CYXO | ST

Overview

Corporate Details

ISIN(s):
SE0007815428 (+2 more)
LEI:
54930034OH16ROAY4K87
Country:
Sweden
Address:
Hyllie Boulevard 34, 215 32 Malmö

Description

Cyxone AB is a clinical-stage biotechnology company focused on developing disease-modifying therapies for autoimmune and autoinflammatory diseases. The company's portfolio includes two primary drug candidates in clinical development. Rabeximod is an immunomodulating agent being investigated for the treatment of rheumatoid arthritis. T20K is a drug candidate for multiple sclerosis, developed using the company's cyclotide technology platform, which is based on stable, plant-derived peptides. Cyxone aims to develop therapies that can significantly improve the quality of life for patients with these chronic conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cyxone AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cyxone AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cyxone AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-06-28 Carl Magnus Högerkorp Other Buy 64,950 40,788.60 SEK
2023-06-27 Carl Magnus Högerkorp Other Buy 6,050 3,690.50 SEK
2023-03-03 Carl Magnus Högerkorp Other Buy 100,010 51,005.10 SEK
2023-03-02 Carl Magnus Högerkorp Other Buy 10,873 5,653.96 SEK
2021-07-15 Bert Junno Other Other 1,788,732 7,763,096.88 SEK
2021-07-15 Bert Junno Other Other 1,788,732 N/A
2021-07-14 Bert Junno Other Other 1,788,786 7,790,163.03 SEK
2021-07-14 Bert Junno Other Other 1,788,786 N/A
2021-07-12 Mikeoo Holding AB Other Other 1,788,732 7,441,125.12 SEK
2021-07-12 Mikael Lindstam Other Other 1,788,732 N/A

Peer Companies

CRONEX.CO.,LTD Logo
A CRO supplying biological species and bio-tissue materials for medical research.
South Korea
215570
C&R Research Inc. Logo
A full-service CRO providing clinical research for pharma and medical device companies.
South Korea
359090
Cte Group Spolka Akcyjna Logo
Diversified firm in HR services, corporate events, and composite materials.
Poland
LPS
curacle co., ltd. Logo
A clinical-stage biopharma developing drugs for intractable vascular diseases.
South Korea
365270
CytoMed Therapeutics Ltd Logo
Clinical-stage developer of off-the-shelf allogeneic cell immunotherapies for cancer.
United States of America
GDTC
DARWIN AG Logo
Biotechnology firm creating personalized products from individual biological data.
Germany
7V0
DEINOVE Logo
Develops compounds from rare bacteria for cosmetics and new antibiotics.
France
ALDEI
Delta Drone Logo
Develops drone-based systems for the logistics, security, and military sectors.
France
ALDR
Delta-Fly Pharma, Inc. Logo
Biopharmaceutical firm developing novel anticancer drugs from existing components.
Japan
4598
DG INNOVATE PLC Logo
Develops sustainable technologies for electric mobility and energy storage solutions.
United Kingdom
DGI

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.